AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17592313 — intervention group
Group type: EXPERIMENTAL
Intervention: ketorolac tromethamine 0.4% (Acular LS)
Number of subjects: 7
Study 17592313 — intervention group
Group type: COMPARATOR
Intervention: nepafenac sodium 0.1% (Nevanac)
Number of subjects: 7
Study 15860498 — intervention group
Group type: EXPERIMENTAL
Intervention: Circular excision and subsequent stripping
Number of subjects: 48
Study 15860498 — intervention group
Group type: COMPARATOR
Intervention: Immediate stripping
Number of subjects: 48
Study 15860498 — intervention group
Group type: EXPERIMENTAL
Intervention: Stripping
Number of subjects: 48
Study 15860498 — intervention group
Group type: COMPARATOR
Intervention: Coagulation and cutting
Number of subjects: 48
Study 12138270 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux polysulfone
Number of subjects: 0
Study 12138270 — intervention group
Group type: COMPARATOR
Intervention: Low-flux polysulfone
Number of subjects: 0
Study 12138270 — intervention group
Group type: COMPARATOR
Intervention: Cuprophan
Number of subjects: 0
Study 9734730 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term dietary olive oil intervention (MUFA diet)
Number of subjects: 23
Study 9734730 — intervention group
Group type: COMPARATOR
Intervention: Control (SFA-enriched diet)
Number of subjects: 23
Study 8091152 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based health counselling programme
Number of subjects: 118
Study 8091152 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 118
Study 3041937 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolazamide
Number of subjects: 15
Study 3041937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 31609882 — intervention group
Group type: EXPERIMENTAL
Intervention: DaxibotulinumtoxinA (DAXI) 40 U
Number of subjects: 609
Study 29363329 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural control intervention
Number of subjects: 0
Study 29363329 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 26586266 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional interventions aimed at diminishing neuropsychiatric symptoms in dementia patients and improving caregiver's sense of competence.
Number of subjects: 0
Study 26332473 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (E) - focused didactic lecture and periodic e‐mail reminders with immediate feedback
Number of subjects: 244
Study 26332473 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 244
Study 23782622 — intervention group
Group type: EXPERIMENTAL
Intervention: DSMS delivered by educator
Number of subjects: 141
Study 23782622 — intervention group
Group type: EXPERIMENTAL
Intervention: DSMS delivered by peer
Number of subjects: 141
Study 23782622 — intervention group
Group type: EXPERIMENTAL
Intervention: DSMS delivered by practice staff
Number of subjects: 141
Study 23782622 — intervention group
Group type: COMPARATOR
Intervention: Usual education (control)
Number of subjects: 141
Study 23782622 — intervention group
Group type: EXPERIMENTAL
Intervention: All DSMS groups
Number of subjects: 141
Study 23782622 — intervention group
Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 141
Study 21346095 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Testosterone (TT)
Number of subjects: 1489
Study 21346095 — intervention group
Group type: EXPERIMENTAL
Intervention: Free Testosterone (FT)
Number of subjects: 1489
Study 21346095 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Estradiol (E(2))
Number of subjects: 1489
Study 21346095 — intervention group
Group type: EXPERIMENTAL
Intervention: Free Estradiol (E(2))
Number of subjects: 1489
Study 18501066 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0
Study 18501066 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole plus Lapatinib
Number of subjects: 0
Study 17575805 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly purified omega-3 polyunsaturated fatty acids (PUFAs) at a dose of 1 g/day
Number of subjects: 0
Study 17575805 — intervention group
Group type: COMPARATOR
Intervention: Standard secondary pharmacological prevention therapy (anti-platelet agents, statins, beta-blockers, ACE inhibitors)
Number of subjects: 0
Study 17575805 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly purified omega-3 PUFAs
Number of subjects: 0
Study 14530016 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent antegrade cold blood cardioplegia
Number of subjects: 39
Study 14530016 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent retrograde cold blood cardioplegia
Number of subjects: 39
Study 10894877 — intervention group
Group type: EXPERIMENTAL
Intervention: Daniplestim (2.5 microgram/kg/d) plus G-CSF (10 microgram/kg/d)
Number of subjects: 52
Study 10894877 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus G-CSF (10 microgram/kg/d)
Number of subjects: 52
Study 8931033 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium citrate solution (500 mg Ca2+)
Number of subjects: 18
Study 8931033 — intervention group
Group type: COMPARATOR
Intervention: Calcium lactogluconate/carbonate solution (500 mg Ca2+)
Number of subjects: 18
Study 8931033 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium citrate suspension (500 mg Ca2+)
Number of subjects: 18
Study 1486427 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment alone
Number of subjects: 0
Study 1486427 — intervention group
Group type: COMPARATOR
Intervention: Historical control group (not selected according to ER status)
Number of subjects: 0
Study 3917619 — intervention group
Group type: EXPERIMENTAL
Intervention: Active surveillance (weekly telephone contact)
Number of subjects: 216
Study 3917619 — intervention group
Group type: COMPARATOR
Intervention: Passive surveillance (no contact)
Number of subjects: 216
Study 3917619 — intervention group
Group type: EXPERIMENTAL
Intervention: Active surveillance
Number of subjects: 216
Study 31485014 — intervention group
Group type: EXPERIMENTAL
Intervention: Goat lung surfactant extract (GLSE)
Number of subjects: 98
Study 31485014 — intervention group
Group type: COMPARATOR
Intervention: Bovine surfactant extract (beractant; Survanta®)
Number of subjects: 98
Study 30077574 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance + aerobic training
Number of subjects: 36
Study 30077574 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group (stretching)
Number of subjects: 36
Study 27776675 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem Recognition Questionnaire (PRQ) pre-treatment
Number of subjects: 191
Study 27776675 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem Recognition Questionnaire (PRQ) post-treatment
Number of subjects: 191
Study 24556276 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption (beer and spirits)
Number of subjects: 0
Study 24556276 — intervention group
Group type: EXPERIMENTAL
Intervention: Total alcohol volume and drinking in public settings
Number of subjects: 0
Study 22250855 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 99
Study 22250855 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 99
Study 22250855 — intervention group
Group type: COMPARATOR
Intervention: Control (monitored Internet discussion forum)
Number of subjects: 99
Study 20054046 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-alcohol
Number of subjects: 849
Study 20054046 — intervention group
Group type: COMPARATOR
Intervention: Povidone-iodine
Number of subjects: 849
Study 17913408 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy isoflavone extract (250 mg of standardized soy extract, total of 100 mg/day of isoflavone)
Number of subjects: 80
Study 17913408 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 17913408 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy isoflavone extract
Number of subjects: 80
Study 15643102 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg fluoxetine capsules administered rectally
Number of subjects: 7
Study 15643102 — intervention group
Group type: COMPARATOR
Intervention: 20 mg fluoxetine capsules administered orally
Number of subjects: 7
Study 15643102 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal route of administration
Number of subjects: 7
Study 11788642 — intervention group
Group type: COMPARATOR
Intervention: 1 mg oral dexamethasone test
Number of subjects: 121
Study 11788642 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.0035 mg oral dexamethasone per kg
Number of subjects: 121
Study 11788642 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.0070 mg oral dexamethasone per kg
Number of subjects: 121
Study 11788642 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.015 mg oral dexamethasone per kg
Number of subjects: 121
Study 11788642 — intervention group
Group type: EXPERIMENTAL
Intervention: All variable-dose tests
Number of subjects: 121
Study 11788642 — intervention group
Group type: EXPERIMENTAL
Intervention: All tests
Number of subjects: 121
Study 11788642 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise multiple regression analysis
Number of subjects: 121
Study 11788642 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 121
Study 10784385 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn oil diet (80 g of corn oil, 20 mg alpha‐tocopherol, 100 mg gamma‐tocopherol)
Number of subjects: 20
Study 10784385 — intervention group
Group type: COMPARATOR
Intervention: Olive/sunflower oil diet (80 g of olive/sunflower oil, 24 mg alpha‐tocopherol, 2.4 mg gamma‐tocopherol)
Number of subjects: 20
Study 10784385 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn oil diet
Number of subjects: 20
Study 10784385 — intervention group
Group type: COMPARATOR
Intervention: Olive/sunflower oil diet
Number of subjects: 20
Study 7746909 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol powder (1.6 mg) from the Diskhaler
Number of subjects: 32
Study 7746909 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol nebulizer solution (2.5 ml, 1 mg ml‐1) from a jet nebulizer
Number of subjects: 32
Study 2117011 — intervention group
Group type: EXPERIMENTAL
Intervention: Brooker-Wills femoral nail
Number of subjects: 70
Study 2117011 — intervention group
Group type: COMPARATOR
Intervention: Russell-Taylor femoral nail
Number of subjects: 70
Study 2117011 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 70
Study 6785790 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ) at fixed doses (200, 400, or 600 mg)
Number of subjects: 43
Study 31170973 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention for postpartum diabetes prevention
Number of subjects: 8
Study 31170973 — intervention group
Group type: EXPERIMENTAL
Intervention: Health educators and interviewers' involvement in intervention implementation
Number of subjects: 8
Study 28063397 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic medications
Number of subjects: 159
Study 26457673 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant glasses containing extracts of medicinal plants
Number of subjects: 50
Study 26457673 — intervention group
Group type: COMPARATOR
Intervention: Placebo glasses
Number of subjects: 50
Study 23420053 — intervention group
Group type: EXPERIMENTAL
Intervention: TachoSil®
Number of subjects: 24
Study 23420053 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (stapling/suturing)
Number of subjects: 24
Study 21894690 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 118
Study 21894690 — intervention group
Group type: COMPARATOR
Intervention: Placebo-Acupuncture Control
Number of subjects: 118
Study 19430405 — intervention group
Group type: EXPERIMENTAL
Intervention: Biochemotherapy
Number of subjects: 138
Study 19430405 — intervention group
Group type: COMPARATOR
Intervention: Interferon-alpha-2b (IFN)
Number of subjects: 138
Study 16169641 — intervention group
Group type: EXPERIMENTAL
Intervention: Masai barefoot technology shoes
Number of subjects: 12
Study 16169641 — intervention group
Group type: COMPARATOR
Intervention: Regular shoes
Number of subjects: 12
Study 15260862 — intervention group
Group type: EXPERIMENTAL
Intervention: Coresidence with adult relatives
Number of subjects: 554
Study 15260862 — intervention group
Group type: COMPARATOR
Intervention: Extended households
Number of subjects: 554
Study 10902294 — intervention group
Group type: EXPERIMENTAL
Intervention: self-hypnosis
Number of subjects: 169
Study 10902294 — intervention group
Group type: COMPARATOR
Intervention: autogenic training
Number of subjects: 169
Study 9286853 — intervention group
Group type: COMPARATOR
Intervention: Mibefradil 50 mg
Number of subjects: 3430
Study 9286853 — intervention group
Group type: COMPARATOR
Intervention: Mibefradil 100 mg
Number of subjects: 3430
Study 9286853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3430
Study 9286853 — intervention group
Group type: EXPERIMENTAL
Intervention: Mibefradil
Number of subjects: 3430
Study 9286853 — intervention group
Group type: COMPARATOR
Intervention: Mibefradil 50 mg and 100 mg
Number of subjects: 3430
Study 8393637 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial Natriuretic Peptide (ANP) infusion at 5 ng/kg/min
Number of subjects: 11
Study 8393637 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial Natriuretic Peptide (ANP) infusion
Number of subjects: 11
Study 2947777 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg DMPA
Number of subjects: 1216
Study 2947777 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg DMPA
Number of subjects: 1216
Study 31176889 — intervention group
Group type: EXPERIMENTAL
Intervention: Unguided web-based intervention
Number of subjects: 724
Study 31176889 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 724
Study 30530872 — intervention group
Group type: EXPERIMENTAL
Intervention: STEP (Coordinated Specialty Care)
Number of subjects: 30
Study 30530872 — intervention group
Group type: COMPARATOR
Intervention: Usual Treatment (UT)
Number of subjects: 30
Study 26901242 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlinear resistance training (NLRT)
Number of subjects: 30
Study 26901242 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study 24974240 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoriasis and Arthritis Screening Questionnaire (PASQ)
Number of subjects: 949
Study 24974240 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoriasis Epidemiology Screening Tool (PEST)
Number of subjects: 949
Study 24974240 — intervention group
Group type: EXPERIMENTAL
Intervention: Toronto Psoriatic Arthritis Screen (ToPAS)
Number of subjects: 949
Study 23161187 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance spectroscopy in cirrhotic patients
Number of subjects: 91
Study 20123224 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen supplementation at 2 L/min via nasal cannulae overnight
Number of subjects: 63
Study 20123224 — intervention group
Group type: COMPARATOR
Intervention: Control (room air)
Number of subjects: 63
Study 17406348 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief smoking cessation advice supplemented with written information during cervical smear test appointments
Number of subjects: 242
Study 17406348 — intervention group
Group type: COMPARATOR
Intervention: Control group (no smoking cessation advice)
Number of subjects: 242
Study 17406348 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief smoking cessation advice
Number of subjects: 242
Study 16363902 — intervention group
Group type: COMPARATOR
Intervention: Balloon Angioplasty (BA)
Number of subjects: 147
Study 16363902 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon Angioplasty with adjunctive endovascular brachytherapy (BA+EVBT)
Number of subjects: 147
Study 12225549 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal MgSO(4) infusion (250 mg/kg per day) for 3 days
Number of subjects: 33
Study 12225549 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MgSO(4) infusion)
Number of subjects: 33
Study 9857278 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training for 8 weeks
Number of subjects: 17
Study 9857278 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 17
Study 7883833 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (75 mg, orally)
Number of subjects: 8
Study 2556909 — intervention group
Group type: EXPERIMENTAL
Intervention: All Bran
Number of subjects: 11
Study 2556909 — intervention group
Group type: COMPARATOR
Intervention: Corn Flakes
Number of subjects: 11
Study 860138 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (0.4 milligram)
Number of subjects: 7
Study 860138 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 7
Study 31488204 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioemotional and material learning paradigm (SEMLA)
Number of subjects: 431
Study 31488204 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitally implemented attention and math training paradigm (DIL)
Number of subjects: 431
Study 31488204 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 431
Study 31488204 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up analysis
Number of subjects: 431
Study 31488204 — intervention group
Group type: EXPERIMENTAL
Intervention: Background variables
Number of subjects: 431
Study 29214926 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Training (HIT, n = 31)
Number of subjects: 107
Study 29214926 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Training (LIT, n = 31)
Number of subjects: 107
Study 29214926 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG, n = 45)
Number of subjects: 107
Study 25738891 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based counselor-assisted family problem-solving therapy (CAPS)
Number of subjects: 132
Study 25738891 — intervention group
Group type: COMPARATOR
Intervention: Internet resource comparison (IRC)
Number of subjects: 132
Study 23040589 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent (ZES-R)
Number of subjects: 40
Study 23040589 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 40
Study 21609212 — intervention group
Group type: EXPERIMENTAL
Intervention: Emervel Classic
Number of subjects: 0
Study 21609212 — intervention group
Group type: COMPARATOR
Intervention: Restylane
Number of subjects: 0
Study 18713189 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention for weight loss
Number of subjects: 1388
Study 18713189 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1388
Study 16249666 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 40
Study 16249666 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40
Study 16249666 — intervention group
Group type: COMPARATOR
Intervention: Bispectral Index
Number of subjects: 40
Study 11850141 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide (0, 10, 20, 30, 40% N(2)O in O(2))
Number of subjects: 20
Study 11850141 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide (active doses)
Number of subjects: 20
Study 11850141 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 20
Study 11850141 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100% O(2))
Number of subjects: 20
Study 11850141 — intervention group
Group type: COMPARATOR
Intervention: No-drug option
Number of subjects: 20
Study 10092569 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventricular pacing (n = 115)
Number of subjects: 225
Study 10092569 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial pacing (n = 110)
Number of subjects: 225
Study 10092569 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrial size measured by M mode echocardiography
Number of subjects: 225
Study 7569304 — intervention group
Group type: EXPERIMENTAL
Intervention: Using a wheelchair as a simulation activity
Number of subjects: 0
Study 7569304 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 2168762 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen treatment
Number of subjects: 0
Study 2168762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7357376 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition Memory (RM) group
Number of subjects: 14
Study 7357376 — intervention group
Group type: COMPARATOR
Intervention: Semantic Classification (SC) group
Number of subjects: 14
Study 7357376 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study 30191781 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 67
Study 30191781 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 67
Study 28225313 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel 2% (Tgel) 23 mg/day, uptitrated to 46 mg/day after 2 weeks if necessary, with further adjustments possible on Days 21, 42, and 63.
Number of subjects: 159
Study 28225313 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel 2% (Tgel)
Number of subjects: 159
Study 26241569 — intervention group
Group type: EXPERIMENTAL
Intervention: Online (ONL)
Number of subjects: 32
Study 26241569 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 32
Study 23541791 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine
Number of subjects: 0
Study 23541791 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine and/or Proguanil
Number of subjects: 0
Study 23541791 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone/Proguanil
Number of subjects: 0
Study 23541791 — intervention group
Group type: COMPARATOR
Intervention: Unexposed travelers
Number of subjects: 0
Study 21813914 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate (120 mg/kg body mass)
Number of subjects: 11
Study 21813914 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equal volume)
Number of subjects: 11
Study 21813914 — intervention group
Group type: COMPARATOR
Intervention: No Treatment (NT)
Number of subjects: 11
Study 19114909 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (0.5 mg/kg/hr)
Number of subjects: 72
Study 19114909 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72